Pricing Log in Create free account

Bio-Path Holdings, Inc. (BPTH) vs Moolec Science SA (MLEC)

Bio-Path Holdings, Inc. and Moolec Science SA are both Biotechnology companies. Bio-Path Holdings, Inc. is the larger, with a market value of $1.1M against $620.0K — 1.7× the size. Bio-Path Holdings, Inc. has the higher net margin (0.00% vs −105.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Bio-Path Holdings, Inc. leads on 6 and Moolec Science SA on 6.

Valuation

Metric BPTH MLEC Biotechnology median
P/E n/m n/m 10.60
P/S n/m 0.03 9.40
P/B n/m 0.01 2.13
Price to free cash flow n/m 0.01 25.18
EV/EBITDA 0.00 1.76 0.66
EV/Sales n/m 8.37 9.02
Earnings yield 0.00% (3,822.12%) (32.88%)
Free cash flow yield 0.00% 8,301.70% (23.13%)

Profitability

Metric BPTH MLEC Biotechnology median
Gross margin 0.00% 2,373.25% 68.51%
Operating margin 0.00% 244.93% 0.00%
Net margin 0.00% (105.71%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 157.01% 0.00% (51.96%)
Return on assets (605.50%) 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BPTH MLEC Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 87.75% (793.17%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BPTH MLEC Biotechnology median
Debt to equity 0.00 4.37 0.00
Current ratio 0.07 0.15 4.97
Net debt to EBITDA 0.10 (2.73) 1.01

Dividend

Metric BPTH MLEC Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BPTH MLEC Biotechnology median
Market cap 1.07m 620.00k 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack